191 related articles for article (PubMed ID: 9234750)
1. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.
Tian JH; Kumar S; Kaslow DC; Miller LH
Infect Immun; 1997 Aug; 65(8):3032-6. PubMed ID: 9234750
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
Matsumoto S; Yukitake H; Kanbara H; Yamada T
J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886
[TBL] [Abstract][Full Text] [Related]
3. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains.
Somner EA; Ogun SA; Sinha KA; Spencer Valero LM; Lee JJ; Harrison JA; Holder AA; Hormaeche CE; Khan ACM
Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():221-229. PubMed ID: 10206702
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.
Rénia L; Ling IT; Marussig M; Miltgen F; Holder AA; Mazier D
Infect Immun; 1997 Nov; 65(11):4419-23. PubMed ID: 9353014
[TBL] [Abstract][Full Text] [Related]
5. Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region.
Ahlborg N; Ling IT; Howard W; Holder AA; Riley EM
Infect Immun; 2002 Feb; 70(2):820-5. PubMed ID: 11796616
[TBL] [Abstract][Full Text] [Related]
6. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.
Daly TM; Long CA
Infect Immun; 1993 Jun; 61(6):2462-7. PubMed ID: 8363656
[TBL] [Abstract][Full Text] [Related]
7. Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use.
Ling IT; Ogun SA; Momin P; Richards RL; Garçon N; Cohen J; Ballou WR; Holder AA
Vaccine; 1997 Oct; 15(14):1562-7. PubMed ID: 9330469
[TBL] [Abstract][Full Text] [Related]
8. Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.
Daly TM; Long CA
Infect Immun; 1996 Jul; 64(7):2602-8. PubMed ID: 8698485
[TBL] [Abstract][Full Text] [Related]
9. Immunization against malaria with a recombinant protein.
Ling IT; Ogun SA; Holder AA
Parasite Immunol; 1994 Feb; 16(2):63-7. PubMed ID: 8015856
[TBL] [Abstract][Full Text] [Related]
10. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
[TBL] [Abstract][Full Text] [Related]
11. Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines.
Becker SI; Wang R; Hedstrom RC; Aguiar JC; Jones TR; Hoffman SL; Gardner MJ
Infect Immun; 1998 Jul; 66(7):3457-61. PubMed ID: 9632624
[TBL] [Abstract][Full Text] [Related]
12. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.
Kedzierski L; Black CG; Stowers AW; Goschnick MW; Kaslow DC; Coppel RL
Vaccine; 2001 Sep; 19(32):4661-8. PubMed ID: 11535314
[TBL] [Abstract][Full Text] [Related]
14. Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii.
Kedzierski L; Black CG; Goschnick MW; Stowers AW; Coppel RL
Infect Immun; 2002 Dec; 70(12):6606-13. PubMed ID: 12438332
[TBL] [Abstract][Full Text] [Related]
15. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
[TBL] [Abstract][Full Text] [Related]
16. Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).
Ahlborg N; Ling IT; Holder AA; Riley EM
Infect Immun; 2000 Apr; 68(4):2102-9. PubMed ID: 10722607
[TBL] [Abstract][Full Text] [Related]
17. Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria.
Wipasa J; Hirunpetcharat C; Mahakunkijcharoen Y; Xu H; Elliott S; Good MF
J Immunol; 2002 Jul; 169(2):944-51. PubMed ID: 12097400
[TBL] [Abstract][Full Text] [Related]
18. Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria.
Tian JH; Good MF; Hirunpetcharat C; Kumar S; Ling IT; Jackson D; Cooper J; Lukszo J; Coligan J; Ahlers J; Saul A; Berzofsky JA; Holder AA; Miller LH; Kaslow DC
Parasite Immunol; 1998 Jun; 20(6):263-78. PubMed ID: 9651928
[TBL] [Abstract][Full Text] [Related]
19. Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination.
Stanisic DI; Martin LB; Liu XQ; Jackson D; Cooper J; Good MF
Infect Immun; 2003 Oct; 71(10):5700-13. PubMed ID: 14500491
[TBL] [Abstract][Full Text] [Related]
20. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.
Kawabata Y; Udono H; Honma K; Ueda M; Mukae H; Kadota J; Kohno S; Yui K
Infect Immun; 2002 Nov; 70(11):6075-82. PubMed ID: 12379684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]